INO · NASDAQ · Biotechnology

Inovio Pharmaceuticals (INO)

Develops DNA medicines and CELLECTRA devices, led by INO-3107 for recurrent respiratory papillomatosis.

$1.29
vs last close0.00 (0.00%)